A group of South Korean scientists said Monday they have succeeded in developing a human vaccine against H1N1 Influenza A.
The scientists at Chungnam National University said they cultivated the ``standard virus'' supplied by the U.S. Centers for Disease Control and Prevention (CDC) and created a non-toxic material that can be mass-produced cheaply.
The team, led by Prof. Seo Sang-heui of the college of veterinary medicine of the university based in Daejeon, said the vaccine was developed on Friday, 11 days after the CDC provided the virus sample.